{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:08:23Z","timestamp":1773288503924,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100020192","name":"Medtronic Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020192","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"DOI":"10.1007\/s13300-024-01673-9","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T09:49:34Z","timestamp":1734428974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advanced Hybrid Closed Loop Algorithm Use in Type\u00a01 Diabetes: The French MiniMed\u2122 Glycemic Control and Quality of Life Study"],"prefix":"10.1007","clinical-trial-number":[{"clinical-trial-number":"nct04308291","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Laurence","family":"Kessler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Thivolet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Penfornis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Gouet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Moret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Borot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa\u00efd","family":"Bekka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Sonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Lablanche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Burtin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Di Piazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ohad","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"1673_CR1","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S2213-8587(22)00212-1","volume":"10","author":"P Choudhary","year":"2022","unstructured":"Choudhary P, Kolassa R, Keuthage W, et al. Advanced hybrid closed loop therapy versus conventional treatment in adults with type\u00a01 diabetes (ADAPT): a randomised controlled study. Lancet Diabetes Endocrinol. 2022;10:720\u201331.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1673_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1089\/dia.2023.0433","volume":"26","author":"P Choudhary","year":"2024","unstructured":"Choudhary P, Arrieta A, van den Heuvel T, Casta\u00f1eda J, Smaniotto V, Cohen O. Celebrating the data from 100,000 real-world users of the MiniMed\u2122 780G system in Europe, Middle East, and Africa collected over 3\u00a0years: from data to clinical evidence. Diabetes Technol Ther. 2024;26:32\u20137.","journal-title":"Diabetes Technol Ther"},{"key":"1673_CR3","unstructured":"Ogle GD, Wang F, Gregory GA, Maniam J. Type\u00a01 diabetes estimates in children and adults. Brussels: International Diabetes Federation; 2022. Available from: https:\/\/diabetesatlas.org\/idfawp\/resource-files\/2022\/12\/IDF-T1D-Index-Report.pdf. Accessed on 04 Mar 2024."},{"key":"1673_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.arcped.2021.02.007","volume":"28","author":"M-N Campas-Lebecque","year":"2021","unstructured":"Campas-Lebecque M-N, Pochelu S, Vautier V, et al. Do children and adolescents with type\u00a01 diabetes suffer from a lack of resources in France? Results from a benchmark study in the New Aquitaine region. Arch Pediatr. 2021;28:301\u20136.","journal-title":"Arch Pediatr"},{"key":"1673_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2023.101429","volume":"49","author":"PH Ducluzeau","year":"2023","unstructured":"Ducluzeau PH, Fauchier G, Herbert J, et al. Prevalence and incidence of cardiovascular and renal diseases in type\u00a01 compared with type\u00a02 diabetes: a nationwide French observational study of hospitalized patients. Diabetes Metab. 2023;49: 101429.","journal-title":"Diabetes Metab"},{"key":"1673_CR6","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Methodological guide: real-world studies for the assessment of medicinal products and medical devices. Saint-Denis La Plaine: Haute Autorit\u00e9 de Sant\u00e9; 2021. Available from: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-06\/real-world_studies_for_the_assessment_of_medicinal_products_and_medical_devices.pdf. Accessed on 05 Mar 2024."},{"key":"1673_CR7","doi-asserted-by":"publisher","first-page":"790","DOI":"10.2337\/dc23-1581","volume":"47","author":"J Casta\u00f1eda","year":"2024","unstructured":"Casta\u00f1eda J, Arrieta A, van den Heuvel T, Battelino T, Cohen O. Time in tight glucose range in type\u00a01 diabetes: predictive factors and achievable targets in real-world users of the MiniMed 780G system. Diabetes Care. 2024;47:790\u20137.","journal-title":"Diabetes Care"},{"key":"1673_CR8","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range. Diabetes Care. 2019;42:1593\u2013603.","journal-title":"Diabetes Care"},{"key":"1673_CR9","doi-asserted-by":"publisher","first-page":"530","DOI":"10.2337\/diacare.22.3.530","volume":"22","author":"C Bradley","year":"1999","unstructured":"Bradley C. Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur. Diabetes Care. 1999;22:530\u20132.","journal-title":"Diabetes Care"},{"key":"1673_CR10","unstructured":"Bradley C, Loewenthal K, Woodcock A, McMillan C. Development of the diabetes treatment satisfaction questionnaire (DTSQ) for teenagers and parents: the DTSQ-Teen and the DTSQ-Parent. Diabetologia. Rome: European Association for the Study of Diabetes; 2009. p. S397."},{"key":"1673_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4324\/9781315077369","volume-title":"Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice","author":"C Bradley","year":"2013","unstructured":"Bradley C. Diabetes treatment satisfaction questionnaire (DTSQ). In: Bradley C, editor. Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice. Hove and New York: Psychology Press; 2013. p. 111\u201332."},{"key":"1673_CR12","first-page":"65","volume-title":"Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice","author":"AM Jacobson","year":"2013","unstructured":"Jacobson AM, DCCT Research Group. The diabetes quality of life measure. In: Bradley C, editor. Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice. Hove and New York: Psychology Press; 2013. p. 65\u201388."},{"key":"1673_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/014572179101700219","volume":"17","author":"GM Ingersoll","year":"1991","unstructured":"Ingersoll GM, Marrero DG. A modified quality-of-life measure for youths: psychometric properties. Diabetes Educ. 1991;17:114\u20138.","journal-title":"Diabetes Educ"},{"key":"1673_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2217\/dmt.11.60","volume":"1","author":"L Gonder-Frederick","year":"2011","unstructured":"Gonder-Frederick L, Nyer M, Shepard JA, Vajda K, Clarke W. Assessing fear of hypoglycemia in children with type\u00a01 diabetes and their parents. Diabetes Manag. 2011;1:627\u201339.","journal-title":"Diabetes Manag"},{"key":"1673_CR15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2337\/dc10-1343","volume":"34","author":"LA Gonder-Frederick","year":"2011","unstructured":"Gonder-Frederick LA, Schmidt KM, Vajda KA, et al. Psychometric properties of the hypoglycemia fear survey-II for adults with type\u00a01 diabetes. Diabetes Care. 2011;34:801\u20136.","journal-title":"Diabetes Care"},{"key":"1673_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/dia.2021.0203","volume":"24","author":"JD Silva","year":"2022","unstructured":"Silva JD, Lepore G, Battelino T, et al. Real-world performance of the MiniMed\u2122 780G system: first report of outcomes from 4120 users. Diabetes Technol Ther. 2022;24:113\u20139.","journal-title":"Diabetes Technol Ther"},{"key":"1673_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1089\/dia.2016.0421","volume":"19","author":"SK Garg","year":"2017","unstructured":"Garg SK, Weinzimer SA, Tamborlane WV, et al. Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type\u00a01 diabetes. Diabetes Technol Ther. 2017;19:155\u201363.","journal-title":"Diabetes Technol Ther"},{"key":"1673_CR18","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna: R Core Team; 2023. Available from: https:\/\/www.r-project.org\/. Accessed on 22 Feb 2024."},{"key":"1673_CR19","unstructured":"Wickham H. ggplot2: elegant graphics for data analysis. New York, NY: Springer; 2016. Available from: https:\/\/ggplot2.tidyverse.org. Accessed on 22 Feb 2024."},{"key":"1673_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1089\/dia.2023.0414","volume":"26","author":"S Lablanche","year":"2024","unstructured":"Lablanche S, Delageni\u00e8re J, Jalbert M, et al. 12-month real-life efficacy of the MiniMed 780G advanced closed-loop system in patients living with type\u00a01 diabetes: a French observational, retrospective, multicentric study. Diabetes Technol Ther. 2024;26:426\u201332.","journal-title":"Diabetes Technol Ther"},{"key":"1673_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1089\/dia.2021.0319","volume":"24","author":"AL Carlson","year":"2022","unstructured":"Carlson AL, Sherr JL, Shulman DI, et al. Safety and glycemic outcomes during the MiniMed\u2122 advanced hybrid closed-loop system pivotal trial in adolescents and adults with type\u00a01 diabetes. Diabetes Technol Ther. 2022;24:178\u201389.","journal-title":"Diabetes Technol Ther"},{"key":"1673_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/dom.15344","volume":"26","author":"Z Henry","year":"2024","unstructured":"Henry Z, Villar Fimbel S, Bendelac N, Perge K, Thivolet C. Beneficial effects of automated insulin delivery over one-year follow-up in real life for youths and adults with type\u00a01 diabetes irrespective of patient characteristics. Diabetes Obes Metab. 2024;26:557\u201366.","journal-title":"Diabetes Obes Metab"},{"key":"1673_CR23","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1177\/19322968241234072","volume":"18","author":"AL Carlson","year":"2024","unstructured":"Carlson AL, Graham TE, Akturk HK, et al. Control-IQ technology use in individuals with high insulin requirements: results from the multicenter Higher-IQ trial. J Diabetes Sci Technol. 2024;18:1288\u201392.","journal-title":"J Diabetes Sci Technol"},{"key":"1673_CR24","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1111\/dom.15008","volume":"25","author":"P-Y Benhamou","year":"2023","unstructured":"Benhamou P-Y, Adenis A, Lebbad H, et al. One-year real-world performance of the DBLG1 closed-loop system: data from 3706 adult users with type\u00a01 diabetes in Germany. Diabetes Obes Metab. 2023;25:1607\u201313.","journal-title":"Diabetes Obes Metab"},{"key":"1673_CR25","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1111\/dom.14714","volume":"24","author":"A Arrieta","year":"2022","unstructured":"Arrieta A, Battelino T, Scaramuzza AE, et al. Comparison of MiniMed 780G system performance in users aged younger and older than 15\u00a0years: evidence from 12 870 real-world users. Diabetes Obes Metab. 2022;24:1370\u20139.","journal-title":"Diabetes Obes Metab"},{"key":"1673_CR26","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1111\/dom.15023","volume":"25","author":"B Grassi","year":"2023","unstructured":"Grassi B, G\u00f3mez AM, Calliari LE, et al. Real-world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system. Diabetes Obes Metab. 2023;25:1688\u201397.","journal-title":"Diabetes Obes Metab"},{"key":"1673_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/dia.2023.0453","volume":"26","author":"JR Thrasher","year":"2024","unstructured":"Thrasher JR, Arrieta A, Niu F, et al. Early real-world performance of the MiniMed\u2122 780G advanced hybrid closed-loop system and recommended settings use in the United States. Diabetes Technol Ther. 2024;26:24\u201331.","journal-title":"Diabetes Technol Ther"},{"key":"1673_CR28","doi-asserted-by":"publisher","first-page":"7623","DOI":"10.3390\/ijerph18147623","volume":"18","author":"M-K Cho","year":"2021","unstructured":"Cho M-K, Kim M-Y. What affects quality of life for people with type\u00a01 diabetes?: A cross-sectional observational study. Int J Environ Res Public Health. 2021;18:7623.","journal-title":"Int J Environ Res Public Health"},{"key":"1673_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-001125","volume":"8","author":"C Pritlove","year":"2020","unstructured":"Pritlove C, Markowitz B, Mukerji G, Advani A, Parsons JA. Experiences and perspectives of the parents of emerging adults living with type\u00a01 diabetes. BMJ Open Diabetes Res Care. 2020;8:e001125.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1673_CR30","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3111\/13696998.2011.610852","volume":"14","author":"C Fidler","year":"2011","unstructured":"Fidler C, Elmelund Christensen T, Gillard S. Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs. J Med Econ. 2011;14:646\u201355.","journal-title":"J Med Econ"},{"key":"1673_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2023-003394","volume":"11","author":"ME Peter","year":"2023","unstructured":"Peter ME, Rioles N, Liu J, et al. Prevalence of fear of hypoglycemia in adults with type\u00a01 diabetes using a newly developed screener and clinician\u2019s perspective on its implementation. BMJ Open Diabetes Res Care. 2023;11: e003394.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1673_CR32","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.2337\/dc22-0470","volume":"45","author":"B Matejko","year":"2022","unstructured":"Matejko B, Juza A, Kie\u0107-Wilk B, et al. Transitioning of people with type\u00a01 diabetes from multiple daily injections and self-monitoring of blood glucose directly to MiniMed 780G advanced hybrid closed-loop system: a two-center, randomized, controlled study. Diabetes Care. 2022;45:2628\u201335.","journal-title":"Diabetes Care"},{"key":"1673_CR33","doi-asserted-by":"publisher","first-page":"1210756","DOI":"10.3389\/fendo.2023.1210756","volume":"14","author":"K Cyranka","year":"2023","unstructured":"Cyranka K, Matejko B, Juza A, et al. Quality of life in the course of a one-year use of an advanced hybrid closed-loop system in adults with type\u00a01 diabetes previously na\u00efve to advanced diabetes technology. Front Endocrinol. 2023;14:1210756.","journal-title":"Front Endocrinol"},{"key":"1673_CR34","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s13300-023-01501-6","volume":"15","author":"S Passanisi","year":"2024","unstructured":"Passanisi S, Lombardo F, Mameli C, et al. Safety, metabolic and psychological outcomes of Medtronic MiniMed 780G\u2122 in children, adolescents and young adults: a systematic review. Diabetes Ther. 2024;15:343\u201365.","journal-title":"Diabetes Ther"},{"key":"1673_CR35","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.endinu.2023.06.005","volume":"79","author":"V Navas Moreno","year":"2023","unstructured":"Navas Moreno V, Sebastian-Valles F, Sampedro-Nu\u00f1ez M, Lahera Vargas M, Marazuela M, Arranz Martin JA. Patient satisfaction in three advanced hybrid closed-loop systems at 6\u00a0months of treatment in adults with type\u00a01 diabetes mellitus: a follow-up study. Endocrinol Diabetes Nutr. 2023;79:548\u201355.","journal-title":"Endocrinol Diabetes Nutr"}],"updated-by":[{"DOI":"10.1007\/s13300-025-01698-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000}}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-024-01673-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-024-01673-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-024-01673-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T06:22:29Z","timestamp":1738909349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-024-01673-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":35,"alternative-id":["1673"],"URL":"https:\/\/doi.org\/10.1007\/s13300-024-01673-9","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s13300-025-01698-8","asserted-by":"object"}]},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13300-025-01698-8","URL":"https:\/\/doi.org\/10.1007\/s13300-025-01698-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Laurence Kessler reports consulting fees from Medtronic, Vertex, Abbott, Novo Nordisk; honoraria or payment for lectures, presentations, and educational events from Johnson and Johnson, Lilly Boehringer, Brothier, GSK, AstraZeneca, Sanofi-Aventis, Novartis, BMS, Elivie, Vertex, ASDIA, ISIS Sant\u00e9, ADIRAL. Charles Thivolet reports personal fees from Abbott Diabetes Care, Glooko, Lilly, Novo Nordisk, Medtronic, and Sanofi and is an advisory board member for Insulet and Medtronic. Alfred Penfornis reports consulting fees from Medtronic, Insulet, Abbott Diabetes, Novo Nordisk, Medtrum, and Sanofi; honoraria or payment for lectures, presentations, speaker bureaus, manuscript writing, and educational events from Novo Nordisk, Medtronic, Insulet, Lilly Diabetes, Sanofi Diabetes, Abbott, AstraZeneca, Dexcom, and Diabeloop; payment for expert testimony and support for travel and attending meetings from Sanofi Diabetes and Isis. Didier Gouet reports honoraria or payment for lectures, presentations in symposium and for participation on advisory board from Lilly, Novo Nordisk, Sanofi, Abbott, Medtronic, Roche, AstraZeneca, LVL, Vitalaire, Isis, NHC, and Dexcom. Christine Coffin reports honoraria or payment for presentations, speaker bureaus and educational events from Novo Nordisk, Medtronic, Insulet, Lilly Diabetes, Sanofi Diabetes and Abbot Diabetes; support for travel and attending meetings from Novo Nordisk and Sanofi. Myriam Moret reports payment for support for travel and attending meetings from Lilly Diabetes, ISIS Diabetes, LVL M\u00e9dical; was an investigator on studies from URGO\u00a0Laboratories and from TIMKL. Sophie Borot reports honoraria or payment for lectures, presentations, speaker bureaus, manuscript writing, and educational events from Novo Nordisk, Medtronic, Insulet, Lilly Diabetes, Sanofi Diabetes, and Dexcom. Sa\u00efd Bekka reports consulting fees from Novo Nordisk, Lilly Diabetes, Sanofi, Medtronic, Dexcom, AstraZeneca; participation on advisory boards for Medtronic, Lilly, and Novo Nordisk. Emmanuel Sonnet reports consulting fees from Medtronic, Abbott Diabetes, Glooko and Lilly Diabetes; honoraria or payment for lectures, presentations, speaker bureaus, manuscript writing, and educational events from Novo Nordisk, Medtronic, Dexcom, Tandem, Ypsomed, Sanofi Diabetes, and Glooko. Michael Joubert reports consultant and\/or speaker fees and\/or research support from Abbott, Air Liquide Sant\u00e9 International, Amgen, Asdia, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Dexcom, Dinno Sant\u00e9, Glooko, Insulet, Lifescan, Lilly, LVL M\u00e9dical, Medtronic, MSD, Nestl\u00e9 HomeCare, Novo Nordisk, Organon, Orkyn, Roche Diabetes, Sanofi, Tandem, Vitalaire, Voluntis, and Ypsomed as well as being an Editorial Board member of Diabetes Therapy (Michael Joubert was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions). Sandrine Lablanche reports consulting fees from Medtronic, Dexcom, Ypsomed and Sanofi; honoraria or payment for lectures, presentations, and educational events from Medtronic, Insulet, Lilly Diabetes, Sanofi Diabetes, Vitalaire, Abbott, and Boehringer. Geoffrey Burtin is a current employee of Medtronic. Fabio Di Piazza is a current employee of Medtronic. Tim van den Heuvel is a current employee of Medtronic. Ohad Cohen is a current employee of Medtronic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"All participants or, for minors, their guardians provided informed consent. The study was approved by the French Central Ethics Committee (Comit\u00e9 de Protection des Personnes Sud-Est\u00a0II; 2019-A01668-49; January 8, 2020) and conducted in accordance with the Helsinki Declaration of 1964 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics\/Ethics Approval"}}]}}